scholarly article | Q13442814 |
P356 | DOI | 10.1080/13697130802479580 |
P698 | PubMed publication ID | 19012050 |
P2093 | author name string | M Erenus | |
K Sezer Ozer | |||
T Yoldemir | |||
P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
C-reactive protein, inflammation, and coronary risk | Q33843636 | ||
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study | Q34184063 | ||
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure | Q40510836 | ||
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women | Q40608305 | ||
Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment | Q40769278 | ||
Inflammation in ischaemic heart disease | Q43187895 | ||
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women | Q43758821 | ||
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study | Q43788768 | ||
The in vivo human metabolism of tibolone | Q43855683 | ||
Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen | Q43933082 | ||
A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women | Q43992057 | ||
Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women | Q44150997 | ||
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial | Q44155838 | ||
The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial | Q44205516 | ||
Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries | Q44303599 | ||
Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women | Q44460526 | ||
Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study | Q46472616 | ||
P433 | issue | 1 | |
P304 | page(s) | 66-71 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Climacteric | Q5133381 |
P1476 | title | The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women | |
P478 | volume | 12 |
Q89993571 | Cardiovascular Risk/Benefit Profile of MHT |
Q45152775 | Distribution and determinants of C-reactive protein in the older adult population: European Prospective Investigation into Cancer-Norfolk study |
Q44518503 | Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study |
Q37768413 | Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials |
Search more.